ARYx Therapeutics, Inc. Stock
Stocks
ARYX
US0433871094
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.000001 USD | -.--% |
|
-.--% | - |
| Market Cap | 9.03M 7.92M 7.32M 6.73M 12.7M 871M 12.91M 87.53M 34.31M 426M 33.93M 33.19M 1.47B | P/E 2008 |
-1.76x | P/E 2009 | -2.66x |
|---|---|---|---|---|---|
| Enterprise Value | 11.41M 10M 9.24M 8.5M 16.04M 1.1B 16.29M 110M 43.31M 538M 42.83M 41.89M 1.85B | EV / Sales 2008 |
4,019,605x | EV / Sales 2009 | - |
| Free-Float |
100% | Yield 2008 * |
-
| Yield 2009 | - |
| 5 years | 0 |  | 0.04 |
| 10 years | 0 | | 0.05 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 33 | |
| +0.21% | -0.79% | +53.17% | +57.39% | 53.83B | |
| +5.37% | +0.75% | +50.39% | +83.03% | 52.1B | |
| -1.20% | -1.94% | +4.35% | +402.68% | 23.48B | |
| +0.74% | +2.32% | -16.23% | -14.44% | 23.13B | |
| +3.46% | +0.79% | +34.01% | -4.47% | 19.36B | |
| -1.18% | -1.15% | +30.12% | -32.02% | 17.56B | |
| -1.67% | -8.56% | +163.95% | +284.69% | 15.2B | |
| +3.62% | -2.42% | +29.70% | +663.64% | 14.83B | |
| -0.70% | -0.91% | +24.87% | +179.47% | 14.06B | |
| Average | +0.87% | -1.51% | +41.59% | +179.99% | 23.36B | |
| Weighted average by Cap. | +1.48% | -1.67% | +41.46% | +139.49% |
| 2008 | 2009 | |
|---|---|---|
| Net sales | 19.72 17.29 15.98 14.7 27.73 1.9K 28.18 191.08 74.9 930.63 74.06 72.45 3.21K | - |
| Net income | -31.22M -27.36M -25.29M -23.26M -43.89M -3.01B -44.59M -302M -119M -1.47B -117M -115M -5.07B | -33.17M -29.07M -26.87M -24.71M -46.63M -3.2B -47.38M -321M -126M -1.56B -125M -122M -5.39B |
| Net Debt | -29.9 -26.21 -24.23 -22.28 -42.04 -2.88K -42.72 -289.71 -113.57 -1.41K -112.29 -109.84 -4.86K | 2.37 2.08 1.92 1.77 3.33 228.64 3.39 22.97 9 111.87 8.9 8.71 385.43 |
Employees
56
- Stock Market
- Stocks
- ARYX Stock
Select your edition
All financial news and data tailored to specific country editions
